Diabetes mellitus and SARS-CoV-2 infection: pathophysiologic mechanisms and implications in management.

CONCLUSION: This review summarizes the pathophysiologic mechanisms underlying the co-existence of both pandemics as well as the current recommendations and future perspectives regarding optimal treatment of inpatients and outpatients with DM in the era of SARS-CoV-2 infection. Notably, the current recommended drugs for the treatment of severe COVID-19, dexamethasone and remdesivir, may cause hyperglycemia, an adverse effect that physicians should bear in mind, when caring for patients with DM and COVID-19. PMID: 33388022 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/33388022?dopt=Abstract

Source: Current Diabetes Reviews - December 31, 2020 Category: Endocrinology Authors: Vallianou NG, Evangelopoulos A, Kounatidis D, Stratigou T, Christodoulatos GS, Karampela I, Dalamaga M Tags: Curr Diabetes Rev Source Type: research